Bcl9 Antibody | 22-491

Bcl9 Antibody | 22-491 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse, Rat

Homology: N/A

Immunogen: Recombinant protein of mouse Bcl9

Research Area: Cancer, Cell Cycle, Stem Cell, Transcription

Tested Application: WB, IHC

Application: WB: 1:500 - 1:2000
IHC: 1:50 - 1:200

Specificiy: N/A

Positive Control 1: MCF7

Positive Control 2: Mouse pancreas

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: Observed: 160kDa/170kDa

Validation: N/A

Isoform: N/A

Purification: Affinity purification

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Concentration: N/A

Storage Condition: Store at -20˚C. Avoid freeze / thaw cycles.

Alternate Name: 2610202E01Rik, 8030475K17Rik, A330041G23Rik, Gm13B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, bcl-9, nuclear co-factor of beta-catenin signalling

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.